VEXT Share Price Performance
CA$0.27
-0.04 (-13.11%)
72.1% undervalued intrinsic discount
CA$0.95
Fair Value
Price CA$0.27
AnalystConsensusTarget CA$0.95
AnalystLowTarget CA$0.40
AnalystHighTarget CA$0.95
Fair ValueCA$0.95
Share Pricen/a
Vext Science, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
VEXT Community Narratives
AN
Fair Value
·Fair Value CA$0.95 72.1% undervalued intrinsic discount
Adult Use Expansion And Cultivation Gains Will Drive Stronger Long Term Cannabis Fundamentals
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value CA$0.4 33.8% undervalued intrinsic discount
Regulatory Delays And Oversupply May Pressure Cannabis Margins Yet Long-Term Normalization Should Help
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value CA$0.95 72.1% undervalued intrinsic discount
Adult Use Adoption And Yield Gains Will Drive Strong Future Cannabis Cash Flows
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Vext Science
72.1% undervalued intrinsic discount
Adult Use Expansion And Cultivation Gains Will Drive Stronger Long Term Cannabis Fundamentals
View narrativeAN
Updated 26 Jun
Vext Science
33.8% undervalued intrinsic discount
Regulatory Delays And Oversupply May Pressure Cannabis Margins Yet Long-Term Normalization Should Help
View narrativeAN
Published 4 Jan
Vext Science
72.1% undervalued intrinsic discount
Adult Use Adoption And Yield Gains Will Drive Strong Future Cannabis Cash Flows
View narrativeAN
Published 21 Dec 2025
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
VEXT: Ohio Expansion And Arizona Exit Will Support Future Earnings Potential
Fair Value: CA$0.95 72.1% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Regulatory Delays And Oversupply May Pressure Cannabis Margins Yet Long-Term Normalization Should Help
Fair Value: CA$0.4 33.8% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Adult Use Adoption And Yield Gains Will Drive Strong Future Cannabis Cash Flows
Fair Value: CA$0.95 72.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Vext Science, Inc. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -0.058
- 38.95%
- -28.39%
- 55.0%
About VEXT
- Founded
- 2015
- Employees
- n/a
- CEO
- WebsiteView website
Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona.
